End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.13 CNY | +0.49% | +6.99% | -31.74% |
Apr. 08 | Lotus Health Group Company Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Lotus Health to Buy 50% of Malaysian MSG Producer | MT |
Sales 2021 | 1.81B 250M | Sales 2022 | 1.69B 233M | Capitalization | 4.82B 666M |
---|---|---|---|---|---|
Net income 2021 | 44M 6.07M | Net income 2022 | 46M 6.35M | EV / Sales 2021 | 2.32 x |
Net cash position 2021 | 1.19B 164M | Net cash position 2022 | 1.35B 186M | EV / Sales 2022 | 2.06 x |
P/E ratio 2021 |
100
x | P/E ratio 2022 |
90.3
x | Employees | 1,413 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 62.05% |
1 day | +0.49% | ||
1 week | +6.99% | ||
Current month | -12.50% | ||
1 month | -19.18% | ||
3 months | -15.54% | ||
6 months | -37.42% | ||
Current year | -31.74% |
Managers | Title | Age | Since |
---|---|---|---|
Tao Li
PSD | President | 52 | 22-08-09 |
Jia Sheng Cao
PSD | President | 40 | 20-05-31 |
Hou Wen Li
CHM | Chairman | 46 | 21-04-19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mao Xin Chen
BRD | Director/Board Member | 68 | 20-02-18 |
Bin Li
BRD | Director/Board Member | 53 | 22-08-28 |
Yi Jun Wang
BRD | Director/Board Member | 55 | 22-08-25 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-23 | 4.13 | +0.49% | 30,727,200 |
24-04-22 | 4.11 | -1.20% | 34,029,800 |
24-04-19 | 4.16 | -0.48% | 36,499,000 |
24-04-18 | 4.18 | -0.95% | 59,223,330 |
24-04-17 | 4.22 | +9.33% | 83,839,400 |
End-of-day quote Shanghai S.E., April 22, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-31.74% | 1.01B | |
+0.05% | 29.14B | |
+13.68% | 11.93B | |
+12.18% | 5.14B | |
+9.21% | 4.14B | |
-17.23% | 3.45B | |
-2.50% | 3.19B | |
-1.96% | 2.93B | |
+26.22% | 2.8B | |
+4.14% | 2.39B |
- Stock Market
- Equities
- 600186 Stock